Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Degryse, F. Colpaert (1986)
Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old java monkey [Macaca cynamolgus fascicularis (Raffles)]Brain Research Bulletin, 16
M. Yahr, R. Duvoisin, M. Schear, R. Barrett, M. Hoehn (1969)
Treatment of parkinsonism with levodopa.Archives of neurology, 21 4
H. Narabayashi (1989)
Stereotaxic Vim thalamotomy for treatment of tremor.European neurology, 29 Suppl 1
High-frequency stimulation of subthalamic nucleus in parkinsonism 389
Graham Graham, Robertson Robertson, Sambrook Sambrook, Crossman Crossman (1990)
Injection of excitatory amino acid antagonists into the pallidal segment of the MPTP‐treated primate reverses motor symptoms of parkinsonismLife Sci., 47
C. Hammond, J. Féger, B. Bioulac, J. Souteyrand (1979)
Experimental hemiballism in the monkey produced by unilateral kainic acid lesion in corpus LuysiiBrain Research, 171
H. Nakanishi, H. Kita, S. Kitai (1991)
Intracellular study of rat entopeduncular nucleus neurons in an in vitro slice preparation: response to subthalamic stimulationBrain Research, 549
F. Sellal, E. Hirsch, F. Lisovoski, V. Mutschler, M. Collard, C. Marescaux (1992)
Contralateral disappearance of parkinsonian signs after subthalamic hematomaNeurology, 42
H. Bergman, T. Wichmann, M. DeLong (1990)
Reversal of experimental parkinsonism by lesions of the subthalamic nucleus.Science, 249 4975
J. Féger, C. Ohye, F. Gallouin, D. Albe-Fessard (1975)
Stereotaxic technique for stimulation and recording in nonanesthetized monkeys: application to the determination of connections between caudate nucleus and substantia nigra.Advances in neurology, 10
H. Klawans, H. Moses, P. Nausieda, D. Bergen, W. Weiner (1976)
Treatment and prognosis of hemiballismus.The New England journal of medicine, 295 24
O. Hornykiewicz (1981)
Brain neurotransmitter changes in Parkinson's disease
C. Hammond, J. Deniau, A. Rizk, J. Féger (1978)
Electrophysiological demonstration of an excitatory subthalamonigral pathway in the ratBrain Research, 151
J. Langston, L. Forno, L. Forno, C. Rebert, I. Irwin (1984)
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkeyBrain Research, 292
E. Evarts (1966)
Pyramidal tract activity associated with a conditioned hand movement in the monkey.Journal of neurophysiology, 29 6
T. Aziz, D. Peggs, M. Sambrook, A. Crossman (1991)
Lesion of the subthalamic nucleus for the alleviation of 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)‐induced parkinsonism in the primateMovement Disorders, 6
P. Robledo, I. Vezole, J. Feger (1988)
Mise en évidence d'un effet excitateur des efférences subthalamo-nigrales et subthalamo-pallidales chez le rat, 307
W. Graham, R. Robertson, M. Sambrook, A. Crossman (1990)
Injection of excitatory amino acid antagonists into the medial pallidal segment of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primate reverses motor symptoms of parkinsonism.Life sciences, 47 18
M. DeLong (1990)
Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 13
W. Miller, M. DeLong (1987)
Altered Tonic Activity of Neurons in the Globus Pallidus and Subthalamic Nucleus in the Primate MPTP Model of Parkinsonism
W. Schultz, A. Studer, G. Jonsson, E. Sundström, I. Mefford (1985)
Deficits in behavioral initiation and execution processes in monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonismNeuroscience Letters, 59
(1983)
What happened to Vim thalarnotomy for Parkinson’s disease
(1988)
Mise en Cvidence d’un effet excitateur
A. Crossman, M. Sambrook, A. Jackson (1980)
Experimental hemiballismus in the baboon produced by injection of a gamma-aminobutyric acid antagonist into the basal gangliaNeuroscience Letters, 20
Burns Rs, C. Chiueh, S. Markey, M. Ebert, D. Jacobowitz, I. Kopin (1983)
A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.Proceedings of the National Academy of Sciences of the United States of America, 80 14
P. Aebischer, M. Goddard (1991)
Treating Parkinson's disease with lesions of the subthalamic nucleus.Science, 252 5002
S. Kitai, H. Kita (1987)
Anatomy and Physiology of the Subthalamic Nucleus: A Driving Force of the Basal Ganglia
Doudet Doudet, Gross Gross, Arluison Arluison, Bioulac Bioulac (1990)
Modification of precentral cortex discharge and EMG activity in monkeys with MPTP‐induced lesions of DA nigral neuronsExp. Brain Res., 80
R. Albin, A. Young, J. Penney (1989)
The functional anatomy of basal ganglia disordersTrends in Neurosciences, 12
I. Mitchell, C. Clarke, S. Boyce, R. Robertson, D. Peggs, M. Sambrook, A. Crossman (1989)
Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNeuroscience, 32
J. Féger, P. Robledo, N. Renwart (1991)
The Subthalamic Nucleus: New Data, New Questions
G. Alexander, M. Crutcher (1990)
Functional architecture of basal ganglia circuits: neural substrates of parallel processingTrends in Neurosciences, 13
A. Parent, Y. Smith (1987)
Organization of efferent projections of the subthalamic nucleus in the squirrel monkey as revealed by retrograde labeling methodsBrain Research, 436
C. Ohye, Hirotaro Narabayashi (1979)
Physiological study of presumed ventralis intermedius neurons in the human thalamus.Journal of neurosurgery, 50 3
(1988)
Chronic Vim-thalamic stimulation in movement disorders
J. Brotchie, I. Mitchell, M. Sambrook, A. Crossman (1991)
Alleviation of parkinsonism by antagonism of excitatory amino acid transmission in the medial segment of the globus pallidus in rat and primateMovement Disorders, 6
(1992)
MPTP - induced 266 - 271 . hemiparkinsonism in monkeys : behavioral , mechanographic , electromyographic and immunohistochemical studies
P. Robledo, J. Féger (1990)
Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological dataBrain Research, 518
In Parkinson's disease the loss of dopaminergic neurons in the substantia nigra is associated with global disorganization of basal ganglia activity and, in particular, with increased activity of the excitatory glutamatergic neurons of the subthalamic nucleus. Recent experimental studies have shown that parkinsonian symptoms can be alleviated by selective lesioning of the subthalamic nucleus in monkeys treated with 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP). We measured the effect of high‐frequency stimulation of the subthalamic nucleus in two unilaterally MPTP‐treated monkeys in order to determine whether it was possible to obtain reversible, gradual and controllable functional impairment of this structure. Clinical, mechanographic and electromyographic results demonstrate that this technique can alleviate parkinsonian rigidity and bradykinesia without causing dyskinesia or hemiballismus. This study supports the hypothesis that the subthalamic nucleus and its excitatory projections have an important role in the mechanisms sustaining the expression of parkinsonian motor changes, and suggests that high‐frequency stimulation of the subthalamic nucleus could be included in treatment for parkinsonism.
European Journal of Neuroscience – Wiley
Published: Apr 1, 1993
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.